Role of Patient’s Age and Comorbidities in Therapy of Chronic Lymphocytic Leukemia by VV Strugov, EA Stadnik, YuV Virts, TO Silina, AYu Zaritskii

Get full text

Effect of IGHV Gene Mutation Status and BCR Structure Stereotypy on Effectiveness of BR Regimen in First-Line Therapy of Chronic Lymphocytic Leukemia by VV Strugov, EA Stadnik, AM Rumyantsev, TO Andreeva, YuV Virts, YuV Mirolyubova, PA Butylin, AYu Zaritskey

Get full text

Role of Superficial CD200 Marker in Differential Diagnosis of Malignant B-Cell Lymphoproliferative Diseases by YuV Mirolyubova, EA Stadnik, TS Nikulina, VV Strugov, TO Andreeva, YuV Virts, RV Grozov, AYu Zaritskey

Get full text

Minimal Residual Disease and IGHV-Genes Mutational Status as the Main Predictors of Response to Bendamustine-Rituximab Therapy in Previously Untreated Chronic Lymphocytic Leukemia by YuV Mirolyubova, EA Stadnik, VV Strugov, TO Andreeva, TS Nikulina, YuV Virts, PA Butylin, AG Rumyantsev, AYu Zaritskey

Get full text

Modern therapy and prognostic factors at chronic lymphoid leucosis. Review of literature and own datas by Ye. A. Stadnik, Ye. A. Nikiteen, Yu. A. Alekseyeva, G. N. Salogub, M. A. Yakubovich, Yu. V. Virts, A. Yu. Zaritsky

Get full text